Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab.
Mukherjee D, Gurm H, Tang WH, Roffi M, Wolski K, Moliterno DJ, Guetta V, Ardissinio D, Bode C, Steg G, Lincoff AM, Topol EJ. Mukherjee D, et al. Among authors: topol ej. Am J Cardiol. 2002 Dec 1;90(11):1198-203. doi: 10.1016/s0002-9149(02)02834-5. Am J Cardiol. 2002. PMID: 12450598 Clinical Trial.
Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.
Gurm HS, Lincoff AM, Lee D, Tang WH, Jia G, Booth JE, Califf RM, Ohman EM, Van de Werf F, Armstrong PW, Guetta V, Wilcox R, Topol EJ; GUSTO V Trial. Gurm HS, et al. Among authors: topol ej. J Am Coll Cardiol. 2004 Feb 18;43(4):542-8. doi: 10.1016/j.jacc.2003.09.038. J Am Coll Cardiol. 2004. PMID: 14975461 Free article. Clinical Trial.
ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy).
Cura FA, Roffi M, Pasca N, Wolski KE, Lincoff AM, Topol EJ, Lauer MS; Global Use of Strategies to Open Occluded Arteries V investigators. Cura FA, et al. Among authors: topol ej. Am J Cardiol. 2004 Oct 1;94(7):859-63. doi: 10.1016/j.amjcard.2004.06.018. Am J Cardiol. 2004. PMID: 15464665 Clinical Trial.
Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial.
Nallamothu BK, Bates ER, Hochman JS, Granger CB, Guetta V, Wilcox RG, White HD, Armstrong PW, Savonitto S, Jia G, Lincoff AM, Topol EJ; GUSTO-V Investigators. Nallamothu BK, et al. Among authors: topol ej. Eur Heart J. 2005 Aug;26(15):1506-12. doi: 10.1093/eurheartj/ehi181. Epub 2005 Mar 30. Eur Heart J. 2005. PMID: 15800019 Clinical Trial.
Relation between previous lipid-lowering therapy and infarct size (creatine kinase-MB level) in patients presenting with acute myocardial infarction.
Aronow HD, Lincoff AM, Quinn MJ, McRae AT, Gurm HS, Houghtaling PL, Granger CB, Harrington RA, Van de Werf F, Topol EJ, Lauer MS; GUSTO IIb and PURSUIT Trial Investigators. Aronow HD, et al. Among authors: topol ej. Am J Cardiol. 2008 Nov 1;102(9):1119-24. doi: 10.1016/j.amjcard.2008.06.032. Epub 2008 Aug 27. Am J Cardiol. 2008. PMID: 18940276 Clinical Trial.
1,218 results